Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2023年5月31日
	新闻
	Lung Cancer: Types, Differences, and Survival Rates - Healthnews Healthnews Lung cancer accounts for 12.4% of all cancers and is the most prevalent cancer worldwide. In the United States, lung cancer has the highest ... 标记为不相关
	Resection of Contralateral Scapular Oligometastasis in Non-small Cell Lung Cancer Post ... Cureus A 74-year-old male was diagnosed with right hilar T4N1M0 squamous cell carcinoma of the lung. Radical oncological treatment was initiated with ... 标记为不相关
	FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset Cure Today The FDA will review repotrectinib for the treatment of certain patients with non-small cell lung cancer. The Food and Drug Administration (FDA) ... 标记为不相关
	Gene Therapy/Osimertinib NSCLC Trial Advances to Phase 2 Expansion - Cancer Network Cancer Network ... identifies a recommended phase 2 dose of quaratusugene ozeplasmid plus osimertinib in the management of advanced non–small cell lung cancer. 标记为不相关
	Notice of Privacy Practices | Southeast Georgia Health System Southeast Georgia Health System Imaging Tests · Preparing for Imaging · Low-Dose CT Lung Cancer Screening · Women's Imaging · Women's Imaging · Mammography. 标记为不相关
	Body Vision Medical: Revolutionizing Pulmonary Cancer Diagnostics - MedTech Outlook MedTech Outlook The reason why lung cancer remains the leading cause of cancer-related deaths worldwide is two-fold. One, systematic screening for lung cancer ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈